Skip to main content
. 2013 Oct 31;110(2):399–408. doi: 10.1038/bjc.2013.688

Figure 2.

Figure 2

Correlation between EIF5A2 expression and 5-year patient survival. (A and B) Overall and disease-specific 5-year survival of all melanoma patients, respectively (P=0.001, log-rank test). (C and D) Overall and disease-specific 5-year survival of PM patients (P=0.001 and P<0.001, respectively, log-rank test). (E and F) Overall and disease-specific 5-year survival of thin (⩽2 mm) melanoma patients (P=0.026 and 0.044, respectively, log-rank test).